SCHEMBL6017459

SCHEMBL6017459

CC1(C)CC(C)(C)c2cc(C(=O)C=Cc3ccc(C(=O)OF)cc3)ccc21

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP26A1 O43174 1/20 0.51
MAPT P10636 6/20 0.47
LMNA P02545 3/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
ATM Q13315 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
NPC1 O15118 2/20 0.47
RARA P10276 1/20 0.46
RARB P10826 1/20 0.46
RARG P13631 1/20 0.46
ABCG2 Q9UNQ0 4/20 0.46
F3 P13726 2/20 0.46
RAB9A P51151 2/20 0.45
HTT P42858 1/20 0.45
TNFRSF1A P19438 2/20 0.45
SNCA P37840 2/20 0.44
XDH P47989 2/20 0.42
P4HB P07237 1/20 0.42
CALM1 P0DP23 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4418790 0.86 RARB (0.63) CYP26A1MAPTLMNANPSR1NPC1
SCHEMBL4418785 0.86 RARB (0.63) CYP26A1MAPTLMNANPSR1NPC1
SCHEMBL9187417 0.82 CYP26A1 (0.60) CYP26A1MAPTLMNAMEN1KMT2A
SCHEMBL9187421 0.82 CYP26A1 (0.60) CYP26A1MAPTLMNAMEN1KMT2A
SCHEMBL9822702 0.80 CYP26A1 (0.48) CYP26A1MAPTLMNARARARARB
SCHEMBL9822716 0.80 CYP26A1 (0.48) CYP26A1MAPTLMNARARARARB
SCHEMBL6017458 0.79 RARB (0.51) CYP26A1LMNANPSR1NPC1RARA
SCHEMBL6017460 0.79 RARB (0.51) CYP26A1LMNANPSR1NPC1RARA
SCHEMBL4315172 0.78 RARB (0.75) CYP26A1LMNAMEN1KMT2ANPSR1
SCHEMBL17302425 0.78 CYP26A1 (0.64) CYP26A1MAPTLMNANPSR1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1704139-A1 DISUBSTITUTED CHALCONE OXIMES AS SELECTIVE AGONISTS OF RAR y RETINOID RECEPTORS Allergan, Inc. (US) 2006-09-27 EP disclosed
WO-2005066116-A1 DISUBSTITUTED CHALCONE OXIMES AS SELECTIVE AGONISTS OF RARϜ RETINOID RECEPTORS ALLERGAN, INC. (US) 2005-07-21 WO disclosed